Wolverine Trading
TRIB

Wolverine Trading’s Trinity Biotech TRIB Stock Holding History

Wolverine Trading’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-67
Closed -$40K – 6710
2021
Q1 		$40K Buy
+67
New +$48.3K ﹤0.01% 5695
2017
Q1 		– Sell
-73
Closed -$68.5K – 4998
2016
Q4 		$76K Buy
+73
New +$75.4K ﹤0.01% 4136

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wolverine Trading's TRIB Position: Q2 2021 in Review

Wolverine Trading sold out of Trinity Biotech (TRIB) in Q2 2021, closing a stake of 67 shares — an estimated $40K sold.

Wolverine Trading first reported a position in TRIB in Q4 2016 and held it in 2 quarters. The position peaked at $76K in Q4 2016. 28 funds tracked by Wall St. Rank hold TRIB as of Q2 2021.

  • Wolverine Trading reported no remaining Trinity Biotech position as of Q2 2021 after selling out during the quarter.
  • Wolverine Trading sold 67 Trinity Biotech shares in Q2 2021, an estimated $40K.
  • Wolverine Trading first reported a position in Trinity Biotech in Q4 2016 and held it in 2 quarters.
  • Wolverine Trading's Trinity Biotech position peaked at $76K in Q4 2016.
  • 28 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.